For many companies, intellectual property (IP) is one of their most valuable assets. Conventionally, companies have attempted to extract value from those assets by developing, manufacturing, and selling products protected by their patents. In the face of today’s growing economic pressures, however, businesses are seeking alternatives to this invent it–sell it model. One alternative, in a growing number of cases, is for the company to develop a strategy to monetize its IP in order to extract value from and otherwise financially leverage its patents.
There is, however, no single, guaranteed strategy for monetizing IP, and determining exactly which path to take when attempting to monetize any particular patent is rarely simple. William Strauss will discuss how to maximize the value of your IP and then select among various approaches to extract that value. Susan Griffen will then focus on one of the most frequently chosen strategies for patent monetization–patent licensing.
Moderator:
Gary C. Ma, Finnegan
Opening Remarks:
Johnsee Lee, Taiwan Bio Industry Organization
Speakers:
Susan H. Griffen, Finnegan
William L. Strauss, Finnegan
Agenda:
08:45 Registration
09:15 Welcome remarks
09:20 Opening remarks
09:30 IP Monetization Strategies for Pharma & Biotech
10:20 Tea break
10:50 Approaches to Licensing in the Biotech/
10:50 Pharmaceutical Industry
11:40 Q&A
MCLE Credit:
Finnegan confirms that this activity has been certified for 2.25 hours of California MCLE credit.
Date and Location:
Friday, March 10, 2017
Conference Rm. 112, 1F, Biotech Building, Biomedical Park
1F, No. 18, Sec. 2, Shengyi Rd., Zhubei City, Hsinchu County 302
新竹生醫園區 生技大樓 112會議室
302新竹縣竹北市生醫路二段18號1樓 (C棟)
Tel: +886-3-6676489
RSVP:
Please RSVP by Wednesday, March 8, 2017. For more information, please contact Ms. Nori Chen at (02)2712-7001 Ext. 113
The event is free of charge. Space is limited to three registrants per company/organization.
